Ischemia and reperfusion injury

Yuan Zhai, Yoichiro Uchida, Bibo Ke, Haofeng Ji, Jerzy W. Kupiec-Weglinski

研究成果: Chapter

抄録

Ischemia reperfusion injury (IRI), one of the key problems in clinical transplantation, is an inevitable consequence of organ procurement and implantation procedure. There are two major stages of IRI with distinct mechanisms of tissue damage: loss of blood supply to the organ, and alterations in local pH, glycogen consumption, and adenosine triphosphate (ATP) depletion. Organ injury is perpetuated by the release of pro-inflammatory cytokines and activation of innate immune cells. The innate immune sensors (Toll-like receptors, RIG-I-like receptor, nucleotide-binding domain-like receptor) are involved in ischemia reperfusion injury. IRI is an inevitable consequence of organ procurement and implantation procedure. The chapter also discusses the current understanding of IRI in immune activation, as well as the conversion of an immunologically quiescent organ to a highly inflammatory one. Identification of new molecular pathways (Tim-1/4, inflammasome) provides targets for new drugs to reduce organ damage.

本文言語English
ホスト出版物のタイトルTransplant Immunology
出版社Wiley-Blackwell
ページ128-141
ページ数14
ISBN(電子版)9781119072997
ISBN(印刷版)9780470658215
DOI
出版ステータスPublished - 12-09-2015
外部発表はい

All Science Journal Classification (ASJC) codes

  • 医学(全般)

フィンガープリント

「Ischemia and reperfusion injury」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル